Download Files:
E3330
SKU
HY-19357-10 mg
Category Reference compound
Tags AP-1;DNA/RNA Synthesis;HIF/HIF Prolyl-Hydroxylase;NF-κB;Reactive Oxygen Species;VEGFR, Cancer; Neurological Disease; Cardiovascular Disease, Cell Cycle/DNA Damage;Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κB;Protein Tyrosine Kinase/RTK
$112 – $995
Products Details
Product Description
– E3330 (APX-3330) is a direct, orally active and selective inhibitor of Ape-1 (apurinic/apyrimidinic endonuclease 1)/Ref-1 (redox factor-1) redox. E3330 is able to impair tumor growth and blocks the activity of NF-κB, AP-1, and HIF-1α in pancreatic cancer. E3330 shows anticancer activities[1][2][3][4][5].
Web ID
– HY-19357
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C21H30O6
References
– [1]Zou GM, et al. Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration. Mol Cancer Ther. 2008 Jul;7(7):2012-21.|[2]Kelley MR, et al. Role of the DNA base excision repair protein, APE1 in cisplatin, oxaliplatin, or carboplatin induced sensory neuropathy. PLoS One. 2014 Sep 4;9(9):e106485.|[3]Nagakawa J, et al. Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats. J Pharmacol Exp Ther. 1993 Jan;264(1):496-500. |[4]Zou GM, et al. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis. J Cell Physiol. 2009 Apr;219(1):209-18.|[5]Manguinhas R, et al. Impact of the APE1 Redox Function Inhibitor E3330 in Non-small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and Invasion. Antioxidants (Basel). 2020 Jun 24;9(6):550.
CAS Number
– 136164-66-4
Molecular Weight
– 378.46
Compound Purity
– 99.34
SMILES
– CCCCCCCCC/C(C(O)=O)=CC1=C(C)C(C(OC)=C(OC)C1=O)=O
Clinical Information
– Phase 2
Research Area
– Cancer; Neurological Disease; Cardiovascular Disease
Solubility
– DMSO : 120 mg/mL (ultrasonic)
Target
– AP-1;DNA/RNA Synthesis;HIF/HIF Prolyl-Hydroxylase;NF-κB;Reactive Oxygen Species;VEGFR
Pathway
– Cell Cycle/DNA Damage;Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κB;Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.